Advanced Neuromodulation Systems Inc. Receives Australian Regulatory And Reimbursement Approval For Rechargeable Chronic Pain System
PLANO, Texas & SYDNEY, Australia--(BUSINESS WIRE)--Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc. (NYSE:STJ), today announced Australian Therapeutic Goods Administration (TGA) regulatory approval for its Eon™ Rechargeable Neurostimulation System. In Australia, the Eon system is fully reimbursable via the private health system.